Quarterly report · Q2
4626.TEDINET S100S48Q
Period2023-04-01 → 2023-09-30
Filed2023-11-06
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥51.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥97.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥52.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥9.1bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥10.5bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥8.7bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥15.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.2bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥8.7bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥10.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥6.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥6.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥7.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥197.9bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥187.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥198.4bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥98.3bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥94.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥99.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥92.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥93.4bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥45.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥47.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥45.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥47.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥57.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥51.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥11.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥22.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥12.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥13.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥111.64 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.7 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥203.71 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.32 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.86 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 50.3% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥148m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥74m |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥34.7bn |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥34.7bn |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥0 |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥7.7bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥49.3bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥49.3bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥0 |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥51.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥51.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥148m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥9.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥1.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥142m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥30m |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥38.7bn |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥38.7bn |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00913-000Electronics Materialsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥10.4bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00913-000Medical And Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥51.1bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥51.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥52.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥52.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥142m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥11.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 501
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of stocks of subsidiaries and affiliates inv cf | Prior1YTDDuration | － | JPY |
| Purchase of stocks of subsidiaries and affiliates inv cf | CurrentYTDDuration | -477000000 | JPY |
| Other net inv cf | Prior1YTDDuration | 12000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -55000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -4456000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -12617000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -1933000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 1571000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | 7000000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 6490000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -5308000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -6201000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -628000000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -0 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -2085000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -2902000000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YTDDuration | 177000000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYTDDuration | 164000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -150000000 | JPY |
| Other net fin cf | CurrentYTDDuration | -140000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -2929000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -1019000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 863000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 942000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 6077000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -1734000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 51152000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 47088000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YTDDuration | 15000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYTDDuration | － | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 57245000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 45353000000 | JPY |
| Trade notes receivable transferred by endorsement | Prior1YearInstant | 610000000 | JPY |
| Trade notes receivable transferred by endorsement | CurrentQuarterInstant | 790000000 | JPY |
| Salaries sga | Prior1YTDDuration | 2074000000 | JPY |
| Salaries sga | CurrentYTDDuration | 2347000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 495000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 436000000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 327000000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 222000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 116000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 131000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -17000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -18000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 2077000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 2438000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00913-000ElectronicsMaterialsReportableSegmentsMember | 38684000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00913-000MedicalAndPharmaceuticalsReportableSegmentsMember | 12388000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 51073000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1721000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |